Metabolic
Triple G (GLP-3)
5 mg
Triple G (GLP-3) 5 mg is an entry-size incretin-class research peptide supplied in a holographic-sealed amber vial, characterized by reverse-phase HPLC purity and mass-spectrometry identity confirmation.
$39.99$49.9920% Off
Technical notes
Research Profile
The 5 mg fill is ideal for pilot assays, method development, and laboratories validating new incretin-receptor protocols before scaling to larger fills.
Net peptide content, purity, and fill weight are stated on the certificate so molar concentrations can be calculated accurately for in vitro receptor and signalling assays.
Handling & reconstitution
Add diluent slowly down the vial wall and swirl gently — do not vortex. Aliquot promptly to avoid freeze-thaw cycling.
Lab assistant
AI Dosing & Reconstitution Assistant
Enter your vial, diluent, and target aliquot in any unit — mcg, mg, g, mL, µL, or U-100 syringe units. Every value is range-checked before generation, and the assistant returns concentration, draw volume, and a reconstitution workflow tailored to Triple G (GLP-3).
Inputs are inside normal laboratory ranges: 2.5 mg/mL, draw 0.1 mL (10 U), ~20 aliquots per vial · aliquot = 250 mcg.
Draw volume in every unit: 0.1 mL · 100 µL · 10 U.
Target aliquot: 250 mcg · 0.25 mg · 0.0003 g.
Dosing schedule generator
Choose a cadence and a time window to lay out a day-by-day plan with per-day and cumulative totals, draw volumes, and vials required. Planning aid for laboratory record-keeping only.
1 aliquot every day
1 – 180 days
- Aliquots
- 14
- Total mass (mcg)
- 3,500
- Total draw
- 1.4 mL
- Vials required
- 0.7
14 active / 0 rest days
250 mcg per aliquot
0.1 mL per aliquot
stock 1 · 1 vial ≈ 14 days
| Day | Date | Times | Daily (mcg) | Draw (mL) | Cumulative (mcg) | Vials |
|---|---|---|---|---|---|---|
| 1 | Sep 12, 2026 Sat | 08:00 | 250 | 0.1 | 250 | 0.05 |
| 2 | Sep 13, 2026 Sun | 08:00 | 250 | 0.1 | 500 | 0.1 |
| 3 | Sep 14, 2026 Mon | 08:00 | 250 | 0.1 | 750 | 0.15 |
| 4 | Sep 15, 2026 Tue | 08:00 | 250 | 0.1 | 1,000 | 0.2 |
| 5 | Sep 16, 2026 Wed | 08:00 | 250 | 0.1 | 1,250 | 0.25 |
| 6 | Sep 17, 2026 Thu | 08:00 | 250 | 0.1 | 1,500 | 0.3 |
| 7 | Sep 18, 2026 Fri | 08:00 | 250 | 0.1 | 1,750 | 0.35 |
| 8 | Sep 19, 2026 Sat | 08:00 | 250 | 0.1 | 2,000 | 0.4 |
| 9 | Sep 20, 2026 Sun | 08:00 | 250 | 0.1 | 2,250 | 0.45 |
| 10 | Sep 21, 2026 Mon | 08:00 | 250 | 0.1 | 2,500 | 0.5 |
| 11 | Sep 22, 2026 Tue | 08:00 | 250 | 0.1 | 2,750 | 0.55 |
| 12 | Sep 23, 2026 Wed | 08:00 | 250 | 0.1 | 3,000 | 0.6 |
| 13 | Sep 24, 2026 Thu | 08:00 | 250 | 0.1 | 3,250 | 0.65 |
| 14 | Sep 25, 2026 Fri | 08:00 | 250 | 0.1 | 3,500 | 0.7 |
| Totals | 3,500 | 1.4 | 3,500 | 0.7 | ||
Planning aid · Laboratory Reference Material · not for human or veterinary administration
Protocol history
Saved protocols for this compound will appear here. Every generated dosing & reconstitution result is stored locally on this device so you can revisit or reprint an earlier version.
Saved calculations across every compound live on the calculation history page.
Literature
Research Citations
Curated entry points into the peer-reviewed record for this compound. Links open indexed searches at the U.S. National Library of Medicine so you can verify the current literature yourself rather than relying on a static citation list.
Compliance
Triple G (GLP-3) is supplied strictly as a laboratory reference material. It is not a drug, supplement, food, or cosmetic, and it is not for therapeutic or diagnostic use, human consumption, or veterinary use. Purchasers are responsible for handling the material in accordance with their institutional and jurisdictional requirements.
← Back to catalogCustomer reviews
Verified Feedback
Rating summary
Loading reviews…
Write a review
Shipping & Returns
Delivery & Refund Policy
Related Peptides
Similar by category, dosage, or research focus.
